Aggregated News From Investment Management Regulators

Press release on the suspension of trading in Mithra Pharmaceuticals

Report/Flag

Please complete the required fields.



ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTHORITY, PUBLISHED IN APPLICATION OF ARTICLE 78 OF THE LAW OF 21 NOVEMBER 2017

Trading in the financial instruments of Mithra Pharmaceuticals, ISIN BE0974283153, on Euronext Brussels is suspended on the request of the company from 18/06/2020 at 14:20 CET until the publication of a press release.

Source link

Regulator Information

Abbreviation: FSMA
Jurisdiction: Belgium

Recent Articles

Retail investors have grown in number, are younger and increasingly use neo-brokers since the Covid crisis

After an initial analysis of the behaviour of retail investors on the stock market conducted in April 2020 during the first lockdown, the Autorité des Marchés Financiers has confirmed the renewed in

The AMF announces two appointments to the Regulatory Policy and International Affairs Directorate (DRAI)

Kheira Benhami has been appointed Chief Economist and Director of the Analysis, Financial Stability and Risks Division at the DRAI as of 2 November, while Ianja Ramananarivo was appointed Head of th

Aclassbank / Bellerophon Group Ltd

Attention! The FMA warns investors against concluding transactions with: Aclassbank / Bellerophon Group Ltd with its registered address apparently in Mauritius and St. Vincent and Grenadines Web: www.aclassbank.com E-Mail:...

Get the latest from Regulatory.News in your inbox!

×